Escaping from immune surveillance and promoting of tumor vascular formation are essential for tumor growth and progression. Myeloid immune suppressor Gr+CD11b+ cells (MISCs) are significantly increased in peripheral blood, spleens and bone marrow of tumor bearing animals and cancer patients. They are unable to process and present antigens and therefore do not induce effective anti-tumor responses. Very recently, we have demonstrated a novel tumor-promoting role of these immune cells. MISCs infiltrate into tumors and constitute about 5% of total cells in murine tumors. They promote tumor vascular development through two mechanisms: 1) promoting tumor angiogenesis via production of MMP9, and deletion of MMP9 in these cells completely abolishes their tumor-promoting ability; 2) directly incorporated into tumor endothelium and contributed to tumor vascular formation through vasculogenesis. Consistent with this observation, MISCs acquire endothelial cell properties in the tumor microenvironment and proangiogenic culture conditions. Based on these findings, we hypothesize that alternative differentiation of MISCs is a strategy used by tumors to benefit their growth not only through immune suppression, but also by promoting tumor vascularization. This proposal will investigate the mechanisms and functional significance of MISCs in tumor vascular development and tumor progression.
Our specific aims are:
Specific Aim 1. Investigate the role of VEGF and Ang1 in MISC production, mobilization, recruitment to tumor sites and cell differentiation to endothelial cells in vivo.
Specific Aim 2. Determine the role and molecular mechanisms of VEGF and Ang1 in tumor-mediated MISC differentiation to endothelial cells in vitro.
Specific Aim 3. Explore the molecular mechanisms that regulate MMP9 expression in MISCs and its functional significance. The proangiogenic role of MISCs induced by tumors might constitute a critical mechanism by which tumors subvert their host. Accomplishment of this study will enhance our understanding of the biology of MISCs in tumor-host interaction. Interventions aimed at eliminating these cells may improve anti-tumor immune response and concurrently inhibit tumor vascular formation. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA108856-01A1
Application #
6988907
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Sussman, Daniel J
Project Start
2005-07-01
Project End
2010-04-30
Budget Start
2005-07-01
Budget End
2006-04-30
Support Year
1
Fiscal Year
2005
Total Cost
$300,200
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Mackert, John R; Qu, Peng; Min, Yongfen et al. (2017) Dual negative roles of C/EBP? in the expansion and pro-tumor functions of MDSCs. Sci Rep 7:14048
Ghose, Sampa; Min, Yongfen; Lin, P Charles (2015) ?-Catenin activates Rho GTPase, promotes lymphangiogenesis and growth of tumor metastases. PLoS One 10:e0116338
Tong, Xiaozhe; Lv, Gang; Huang, Jianhua et al. (2014) Gr-1+CD11b+ myeloid cells efficiently home to site of injury after intravenous administration and enhance diabetic wound healing by neoangiogenesis. J Cell Mol Med 18:1194-202
Huang, Jianhua; Lv, Gang; Min, Yongfen et al. (2013) Intravenous administration of Gr-1+CD11b+ myeloid cells increases neovascularization and improves cardiac function after heart infarction. Int J Cardiol 168:1702-5
Min, Y; Ghose, S; Boelte, K et al. (2011) C/EBP-? regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1?. Oncogene 30:4901-9
Boelte, Kimberly C; Gordy, Laura E; Joyce, Sebastian et al. (2011) Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS One 6:e18534
Boutte, Angela M; McDonald, W Hayes; Shyr, Yu et al. (2011) Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics. PLoS One 6:e22446
Boutte, Angela M; Friedman, David B; Bogyo, Matthew et al. (2011) Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis. FASEB J 25:2626-37
Min, Yongfen; Ren, Xiubao; Vaught, David B et al. (2010) Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res 70:2819-28
DeBusk, Laura M; Boelte, Kimberly; Min, Yongfen et al. (2010) Heterozygous deficiency of delta-catenin impairs pathological angiogenesis. J Exp Med 207:77-84

Showing the most recent 10 out of 20 publications